Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Human albumin is the most abundant protein in human plasma, synthesized primarily by the liver and accounting for approximately 50% of total plasma protein content (UniProt P02768). Its primary biological role is the maintenance of colloid osmotic pressure, which is essential for regulating the distribution of water between the intravascular and interstitial compartments (StatPearls, 2023). In clinical settings, albumin is utilized as a volume expander to treat conditions such as hypovolemia, hemorrhagic shock, and severe burns where fluid resuscitation is required. Beyond its hemodynamic functions, albumin acts as a versatile carrier protein, binding and transporting hormones, fatty acids, bile salts, and a wide array of therapeutic drugs (PubChem). The administration of exogenous albumin helps restore oncotic pressure in patients with hypoalbuminemia or significant fluid loss, thereby stabilizing blood pressure and reducing edema. It also possesses antioxidant properties and acts as a pH buffer within the blood. However, its use must be carefully monitored to avoid complications like hypervolemia or pulmonary edema, particularly in patients with underlying cardiac or renal dysfunction. Therapeutic albumin is typically derived from pooled human plasma and is processed to ensure viral safety.
Human albumin increases the oncotic pressure of the plasma, drawing fluid from the interstitial space into the blood vessels to expand intravascular volume (StatPearls, 2023). It also functions as a transport protein, binding various endogenous and exogenous substances to regulate their free concentration in the blood (UniProt P02768).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human Albumin (ALB).